Acute leukemia is treated with the help of different therapies, which include the use of drugs and radiaotherapy. However, patients who do not respond to the treatment well and those who are at an increased risk of relapse are at an increased risk of relapse.

In allogenic stem cell transplant for leukemia treatment, healthy stem cells are first extracted from the cone marrow of the patient and then injected into the body of the cancer patient. This is typically done after the patient is subjected to chemotherapy and radiation therapy.

Risks associated with allogenic stem cell transplant are many and patients are likely to experience certain side effects after the treatment. There is a possibility of immune rejection by the transplanted stem cells or a immune reaction by the recipients immune system.